Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1995 Sep;96(3):1506–1511. doi: 10.1172/JCI118188

Relationship of the 37,000- and 40,000-M(r) tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA512).

M A Payton 1, C J Hawkes 1, M R Christie 1
PMCID: PMC185775  PMID: 7657822

Abstract

Sera from patients with insulin-dependent diabetes immunoprecipitate 64,000-M(r) proteins, distinct from glutamate decarboxylase, that are cleaved to 37,000- and 40,000-M(r) fragments by trypsin. We investigated possible relationships between 37,000- or 40,000-M(r) fragments of antigen and the tyrosine phosphatase-like protein, IA-2 (ICA512). Antibodies from nondiabetic relatives bound differentially to 37,000- and 40,000-M(r) fragments indicating presence of distinct epitopes. Precursors of these fragments could be separated on immobilized lectins, suggesting different carbohydrate content. Levels of antibodies to 40,000-M(r) fragments were strongly associated with those to the intracellular domain of IA-2. Recombinant intracellular domain of IA-2 blocked binding of antibodies to 40,000-M(r) fragments expressed by insulinoma cells and partially blocked binding to 37,000-M(r) fragments. Furthermore, trypsinization of recombinant intracellular domain of IA-2 generated proteolytic fragments of identical M(r) to the 40,000-M(r) fragments of insulinoma antigen; 37,000-M(r) fragments were not generated. Thus, 40,000-M(r) fragments of islet autoantigen are derived from a protein similar or identical to the tyrosine phosphatase-like molecule, IA-2. The 37,000-M(r) fragments are derived from a different, although related, protein.

Full text

PDF
1506

Images in this article

1508Image
on p.1508
1509Image
on p.1509
1509Image
on p.1509
1510Image
on p.1510

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baekkeskov S., Nielsen J. H., Marner B., Bilde T., Ludvigsson J., Lernmark A. Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins. Nature. 1982 Jul 8;298(5870):167–169. doi: 10.1038/298167a0. [DOI] [PubMed] [Google Scholar]
  2. Baekkeskov S., Warnock G., Christie M., Rajotte R. V., Larsen P. M., Fey S. Revelation of specificity of 64K autoantibodies in IDDM serums by high-resolution 2-D gel electrophoresis. Unambiguous identification of 64K target antigen. Diabetes. 1989 Sep;38(9):1133–1141. doi: 10.2337/diab.38.9.1133. [DOI] [PubMed] [Google Scholar]
  3. Castaño L., Russo E., Zhou L., Lipes M. A., Eisenbarth G. S. Identification and cloning of a granule autoantigen (carboxypeptidase-H) associated with type I diabetes. J Clin Endocrinol Metab. 1991 Dec;73(6):1197–1201. doi: 10.1210/jcem-73-6-1197. [DOI] [PubMed] [Google Scholar]
  4. Christie M. R., Brown T. J., Cassidy D. Binding of antibodies in sera from Type 1 (insulin-dependent) diabetic patients to glutamate decarboxylase from rat tissues. Evidence for antigenic and non-antigenic forms of the enzyme. Diabetologia. 1992 Apr;35(4):380–384. doi: 10.1007/BF00401206. [DOI] [PubMed] [Google Scholar]
  5. Christie M. R., Daneman D., Champagne P., Delovitch T. L. Persistence of serum antibodies to 64,000-Mr islet cell protein after onset of type I diabetes. Diabetes. 1990 Jun;39(6):653–656. doi: 10.2337/diab.39.6.653. [DOI] [PubMed] [Google Scholar]
  6. Christie M. R., Genovese S., Cassidy D., Bosi E., Brown T. J., Lai M., Bonifacio E., Bottazzo G. F. Antibodies to islet 37k antigen, but not to glutamate decarboxylase, discriminate rapid progression to IDDM in endocrine autoimmunity. Diabetes. 1994 Oct;43(10):1254–1259. doi: 10.2337/diab.43.10.1254. [DOI] [PubMed] [Google Scholar]
  7. Christie M. R., Hollands J. A., Brown T. J., Michelsen B. K., Delovitch T. L. Detection of pancreatic islet 64,000 M(r) autoantigens in insulin-dependent diabetes distinct from glutamate decarboxylase. J Clin Invest. 1993 Jul;92(1):240–248. doi: 10.1172/JCI116556. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Christie M. R., Tun R. Y., Lo S. S., Cassidy D., Brown T. J., Hollands J., Shattock M., Bottazzo G. F., Leslie R. D. Antibodies to GAD and tryptic fragments of islet 64K antigen as distinct markers for development of IDDM. Studies with identical twins. Diabetes. 1992 Jul;41(7):782–787. doi: 10.2337/diab.41.7.782. [DOI] [PubMed] [Google Scholar]
  9. Christie M. R., Vohra G., Champagne P., Daneman D., Delovitch T. L. Distinct antibody specificities to a 64-kD islet cell antigen in type 1 diabetes as revealed by trypsin treatment. J Exp Med. 1990 Sep 1;172(3):789–794. doi: 10.1084/jem.172.3.789. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Christie M., Landin-Olsson M., Sundkvist G., Dahlquist G., Lernmark A., Baekkeskov S. Antibodies to a Mr-64,000 islet cell protein in Swedish children with newly diagnosed type 1 (insulin-dependent) diabetes. Diabetologia. 1988 Aug;31(8):597–602. doi: 10.1007/BF00264766. [DOI] [PubMed] [Google Scholar]
  11. Genovese S., Bingley P. J., Bonifacio E., Christie M. R., Shattock M., Bonfanti R., Foxon R., Gale E. A., Bottazzo G. F. Combined analysis of IDDM-related autoantibodies in healthy schoolchildren. Lancet. 1994 Sep 10;344(8924):756–756. doi: 10.1016/s0140-6736(94)92248-9. [DOI] [PubMed] [Google Scholar]
  12. Harrison L. C. Islet cell antigens in insulin-dependent diabetes: Pandora's box revisited. Immunol Today. 1992 Sep;13(9):348–352. doi: 10.1016/0167-5699(92)90170-C. [DOI] [PubMed] [Google Scholar]
  13. Karlsen A. E., Fujimoto W. Y., Rabinovitch P., Dube S., Lernmark A. Effects of sodium butyrate on proliferation-dependent insulin gene expression and insulin release in glucose-sensitive RIN-5AH cells. J Biol Chem. 1991 Apr 25;266(12):7542–7548. [PubMed] [Google Scholar]
  14. Kim J., Namchuk M., Bugawan T., Fu Q., Jaffe M., Shi Y., Aanstoot H. J., Turck C. W., Erlich H., Lennon V. Higher autoantibody levels and recognition of a linear NH2-terminal epitope in the autoantigen GAD65, distinguish stiff-man syndrome from insulin-dependent diabetes mellitus. J Exp Med. 1994 Aug 1;180(2):595–606. doi: 10.1084/jem.180.2.595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Lampasona V., Ferrari M., Bosi E., Pastore M. R., Bingley P. J., Bonifacio E. Sera from patients with IDDM and healthy individuals have antibodies to ICA69 on western blots but do not immunoprecipitate liquid phase antigen. J Autoimmun. 1994 Oct;7(5):665–674. doi: 10.1006/jaut.1994.1051. [DOI] [PubMed] [Google Scholar]
  16. Lan M. S., Lu J., Goto Y., Notkins A. L. Molecular cloning and identification of a receptor-type protein tyrosine phosphatase, IA-2, from human insulinoma. DNA Cell Biol. 1994 May;13(5):505–514. doi: 10.1089/dna.1994.13.505. [DOI] [PubMed] [Google Scholar]
  17. Lefrancois L., Thomas M. L., Bevan M. J., Trowbridge I. S. Different classes of T lymphocytes have different mRNAs for the leukocyte-common antigen, T200. J Exp Med. 1986 May 1;163(5):1337–1342. doi: 10.1084/jem.163.5.1337. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Lu J., Notkins A. L., Lan M. S. Isolation, sequence and expression of a novel mouse brain cDNA, mIA-2, and its relatedness to members of the protein tyrosine phosphatase family. Biochem Biophys Res Commun. 1994 Oct 28;204(2):930–936. doi: 10.1006/bbrc.1994.2549. [DOI] [PubMed] [Google Scholar]
  19. Pan M. G., Rim C., Lu K. P., Florio T., Stork P. J. Cloning and expression of two structurally distinct receptor-linked protein-tyrosine phosphatases generated by RNA processing from a single gene. J Biol Chem. 1993 Sep 15;268(26):19284–19291. [PubMed] [Google Scholar]
  20. Petersen J. S., Dyrberg T., Karlsen A. E., Mølvig J., Michelsen B., Nerup J., Mandrup-Poulsen T. Glutamic acid decarboxylase (GAD65) autoantibodies in prediction of beta-cell function and remission in recent-onset IDDM after cyclosporin treatment. The Canadian-European Randomized Control Trial Group. Diabetes. 1994 Nov;43(11):1291–1296. doi: 10.2337/diab.43.11.1291. [DOI] [PubMed] [Google Scholar]
  21. Pietropaolo M., Castaño L., Babu S., Buelow R., Kuo Y. L., Martin S., Martin A., Powers A. C., Prochazka M., Naggert J. Islet cell autoantigen 69 kD (ICA69). Molecular cloning and characterization of a novel diabetes-associated autoantigen. J Clin Invest. 1993 Jul;92(1):359–371. doi: 10.1172/JCI116574. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Rabin D. U., Pleasic S. M., Palmer-Crocker R., Shapiro J. A. Cloning and expression of IDDM-specific human autoantigens. Diabetes. 1992 Feb;41(2):183–186. doi: 10.2337/diab.41.2.183. [DOI] [PubMed] [Google Scholar]
  23. Rabin D. U., Pleasic S. M., Shapiro J. A., Yoo-Warren H., Oles J., Hicks J. M., Goldstein D. E., Rae P. M. Islet cell antigen 512 is a diabetes-specific islet autoantigen related to protein tyrosine phosphatases. J Immunol. 1994 Mar 15;152(6):3183–3188. [PubMed] [Google Scholar]
  24. Walton K. M., Dixon J. E. Protein tyrosine phosphatases. Annu Rev Biochem. 1993;62:101–120. doi: 10.1146/annurev.bi.62.070193.000533. [DOI] [PubMed] [Google Scholar]
  25. Wilkin T., Mirza I., Armitage M., Casey C., Scott-Morgan L. Insulin autoantibody polymorphisms with greater discrimination for diabetes in humans. Diabetologia. 1988 Sep;31(9):670–674. doi: 10.1007/BF00278750. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES